AMGEN: Patient Engagement & Trial Diversity – Dr. Marisa Cruz Interview
Amgen is leveraging cutting-edge technology, including AI and digital health initiatives, to revolutionize clinical trials and improve patient outcomes. Dr. Marisa Cruz is spearheading this transformation, focusing on addressing healthcare gaps and enhancing patient engagement. The company is already seeing success in improving clinical trial diversity through these innovative approaches. digital engagement empowers patients, allowing them to take a more active role in their health management. Amgen’s commitment to accessibility promises to improve healthcare access globally, reducing cardiovascular incidents. This interview highlights Amgen’s commitment to digital medicine. News Directory 3 recognizes Amgen’s dedication to a patient-centered future. They plan to expand digital health programs, further bridging healthcare gaps. Discover what’s next for Amgen’s pioneering efforts in digital health.
Amgen Focuses on Digital Health, AI to Boost Clinical trial Diversity
Updated June 14, 2025
Amgen is prioritizing technology to bridge critical healthcare gaps and enhance diversity in clinical trials. Dr. Marisa Cruz, vice president of Global Digital Medicine at Amgen, is leading the charge with forward-thinking digital health initiatives.
The company aims to reduce cardiovascular incidents and is innovating with artificial intelligence to improve clinical trial diversity. These technologies are being integrated to improve patient outcomes and broaden healthcare access.
Amgen is also focused on empowering patients through digital engagement, enabling them to take a more active role in managing their health. Cruz highlighted the potential of innovation to improve health outcomes globally by addressing accessibility challenges.
What’s next
Amgen plans to continue expanding its digital health programs, focusing on patient-centered care and leveraging AI and machine learning to further bridge gaps in healthcare accessibility and improve overall patient outcomes.